India, July 22 -- image credit- freepik

Primus Partners, India's leading management consulting firm, has released its latest thought leadership report, "The Leaking Pipeline: How India Loses Nearly 24% of Its Domestic Pharmaceutical Value Before It Generates a Health Outcome", highlighting an estimated annual loss of nearly Rs 48,000 crore across India's pharmaceutical value chain before medicines deliver their intended health outcomes.

The report estimates that nearly one-fourth of India's annual domestic pharmaceutical expenditure is lost due to government stock expiry and overstocking, unused household medicines, substandard and spurious medicines, and downstream treatment failures.

While India has established itself as the "Pharmac...